Search Results 2531-2540 of 18390 for Immunode
Marla Broadfoot, Ph.D. February 23, 2026. Mayo Clinic study identifies mechanism behind immunotherapy resistance in lung cancer featured image.
ROCHESTER, Minn. — For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in[...] ...
The latest direction in cancer treatment has been toward potential cancer vaccines and immunotherapies. As these therapies become standard, continued research ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a ...
ROCHESTER, Minn. — For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in[.
https://www.youtube.com/watch?v=AyWh6Ud85EM A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental ...
Science Saturday: Advancing cell-based regenerative therapy for heart failure featured image · How emerging variants could affect COVID-19 testing, vaccines and ...
The primary purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with pancreatic adenocarcinoma with ...
Dr. Gazelka 00:30. Welcome, everyone to Mayo Clinic Q&A. I'm Dr. Halena Gazelka. Thanks for joining us today. One of the challenges of the COVID-19 pandemic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!